These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 625590)
1. Adenosine as a prostaglandin antagonist. Possible mechanism of the defect in combined immunodeficiency disease due to adenosine deaminase deficiency. Karmali RA; Horrobin DF; Ally AI; Manku MS; Karmazyn M; Morgan RO; Menezes J Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):181-4. PubMed ID: 625590 [TBL] [Abstract][Full Text] [Related]
2. Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes. Snyder FF; Mendelsohn J; Seegmiller JE J Clin Invest; 1976 Sep; 58(3):654-66. PubMed ID: 956393 [TBL] [Abstract][Full Text] [Related]
3. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line. Uberti J; Peterson WD; Lightbody JJ; Johnson RM J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019 [TBL] [Abstract][Full Text] [Related]
9. Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency. Markert ML; Hershfield MS; Wiginton DA; States JC; Ward FE; Bigner SH; Buckley RH; Kaufman RE; Hutton JJ J Immunol; 1987 May; 138(10):3203-6. PubMed ID: 3571974 [TBL] [Abstract][Full Text] [Related]
10. [Adenosine-deaminase defect of erythrocytes and combined immune defect: a new metabolic disease. First experiences with screening tests of the disease and quantitative determination of enzyme activity]. Szüts P; Havass Z; Boda D Orv Hetil; 1977 Oct; 118(41):2457-60. PubMed ID: 917532 [No Abstract] [Full Text] [Related]
12. Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency. Linch DC; Levinsky RJ; Rodeck CH; Maclennan KA; Simmonds HA Clin Exp Immunol; 1984 May; 56(2):223-32. PubMed ID: 6610509 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency. Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression. Chouaib S; Welte K; Mertelsmann R; Dupont B J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362 [TBL] [Abstract][Full Text] [Related]
18. Quantitative immunoassay of adenosine deaminase in combined immunodeficiency disease. Carson DA; Goldblum R; Seegmiller JE J Immunol; 1977 Jan; 118(1):270-3. PubMed ID: 830750 [TBL] [Abstract][Full Text] [Related]
20. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells. Webster AD; Ip H; Pereira S Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]